Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Hypopituitarism)
10,594 results
  • Radiosurgery as primary management for Acromegaly. [Journal Article]
  • CEClin Endocrinol (Oxf) 2018 Oct 04
  • Sims-Williams HP, Rajapaksa K, … Newell-Price J
  • CONCLUSIONS: This is the longest follow up of patients who have undergone primary STRS for acromegaly. It shows low morbidity, but significant latency to biochemical control and new onset hypopituitarism. This mandates very long-term follow-up for these patients. STRS has shown good long-term efficacy providing initial control can be afforded by optimal medical management. While TSS remains best practice, STRS offers an alternative for those in whom surgery is not an option. This article is protected by copyright. All rights reserved.
  • Non-adenomatous sellar lesions: single-centre 10-year experience. [Journal Article]
  • HHormones (Athens) 2018 Oct 03
  • Sousa Santos F, Nunes Dias L, … Ramos S
  • CONCLUSIONS: Although rare, non-adenomatous sellar lesions may be associated with significant causes of morbidity, such as hypopituitarism and visual defects, per se or due to the various treatment modalities employed. Moreover, since the lesions are difficult to distinguish from adenomas, these patients require a careful multidisciplinary approach.
New Search Next